An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA (Q28567837)

31 January 2017

0 references

An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA (English)

1 reference

31 January 2017

1 reference

1 reference

1 reference

Erin M. Falk

1

1 reference

31 January 2017

Valerie J. Cook

series ordinal

2

1 reference

31 January 2017

David E. Nichols

series ordinal

3

1 reference

31 January 2017

Jon E. Sprague

series ordinal

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Pharmacology, Biochemistry and Behavior

31 January 2017

published in

1 reference

31 January 2017

volume

72

1 reference

31 January 2017

issue

3

1 reference

31 January 2017

page(s)

617–622

1 reference

Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Free radicals and the pathobiology of brain dopamine systems

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Active [3H]-dopamine uptake by human lymphocytes: correlates with serotonin transporter activity.

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissue

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(02)00728-1

7 January 2021

10.1016/S0091-3057(02)00728-1

Identifiers

DOI

0 references

1 reference